OECD Report: Tackling Harmful Alcohol Use

New OECD Report a reminder that new Government must tackle alcohol crisis with urgency – BSG

BSG alcohol health experts have responded to today's OECD Report by calling on the new Government to introduce a range of measures to address alcohol-related problems, which cost the Government £21bn every year.

The report, Tackling Harmful Alcohol Use: Economics and Public Health Policy, shows that whilst average alcohol consumption is apparently falling in some European countries:

  • Levels of alcohol consumption in the UK are above the OECD average and have increased during the last 30 years
  • The proportion of 15 year olds who have experienced alcohol increased from 71% in 2002 to 75% in 2010
  • In England, the heaviest-drinking 20% of the population drink almost 63% of all alcohol

The BSG has repeated calls for a range of measures to be introduced to address the current crisis, including the introduction of an Alcohol Care Team in every hospital in the country, the introduction of a 50p minimum unit price for alcohol and restrictions of the advertising of alcohol, particularly towards children.

Commenting, British Society of Gastroenterology Alcohol Services Lead, Dr Kieran Moriarty CBE, said:

"This Europe-wide report comes at a critical moment for Britain, and we hope it will act as an urgent reminder to the incoming Government of the need to introduce a range of evidence-based policies to address the crisis we face.

"We have made considerable progress in recent years by increasing the number of Alcohol Care Teams, but we need more service improvements and for the Government to introduce a whole range of measures to address the situation we face.

"Our A&Es and wards are under great pressure and it is no secret that alcohol misuse has a major part to play in this.

"There is not a family in Britain unaffected by alcohol misuse and taking action will save the NHS money and, more importantly, save lives."


IBD Registry News – July 2015

  • Data on over 5000 patients from 6 hospitals has been submitted via HSCIC to the Registry, analysed and presented at DDF
  • 5 hospitals have the IBD Registry Patient Management System (PMS) installed
  • 15 hospitals have ordered the PMS
  • The first site (Southampton) has been set up using a third-party system (Ascribe)

Patients call for clinicians to use the Registry

Crohn's and Colitis UK Ambassador Rozylnn Prescott called for the clinical community to embrace the IBD Registry, saying it would make life easier for patients. She explained that she was late arriving for the symposium because of a clinic appointment that morning, during which she had to recap her entire medical history to a doctor she hadn't seen before. She commented that the sort of electronic clinical summary provided by the IBD Registry patient management system would be welcomed by patients.

Jeremy Taylor, chief executive of National Voices pointed out that real-time data is being used effectively in all other spheres of 21st Century service provision and called on the clinical community to push their trusts and hospitals to join the Registry so that they could benchmark their service. Both of the patient representatives thought that patients would understand the benefits of participation and would be happy to consent to their data being shared with the Registry.

Over 120 delegates attended IBD in the UK, Improving Patient Outcomes and Experience, which set out the need for better electronic clinical data to be collected routinely. Improve Care Now and the UK Ileal Pouch Registry are just two examples of how data has contributed to tangible improvements in quality and outcomes.

2015 IBD Registry data on over 5000 patients was presented by Keith Bodger, showing the potential of the project to inform service improvement both locally and nationally. The data was successfully uploaded from five hospitals who are using the Registry InfoFlex Patient Management System (PMS) and one using the IBD module provided by Emis (previously Ascribe) system.

Other speakers were David Barker and Helen Terry from Crohn's and Colitis UK, Fraser Cummings, Omar Faiz, Cath Stansfield and Chris Calvert. All the presentations are available at

Crohn's and colitis uk health services development award 2015

The Registry's application for a Crohn's and Colitis UK health services development award has been successful. The project – Maximising the value of the UK IBD Registry for service delivery, audit and research – will be led by Keith Bodger. As well as confirming the feasibility of establishing local IBD registries, the project aims to develop and test new ways to capture, link and analyse information about routine IBD care, and engage with stakeholders to ensure the analytical tools are relevant to local service delivery, commissioning, audit and research.

Participant certificates

We have produced certificates for clinicians who have submitted data to the Registry, for revalidation or appraisal purposes. These will be posted to you, but please contact Simone Cort if you have any queries.

To find out more about joining the Registry click here or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it .


Cancer Genetics in Clinical Practice

A Guide to Cancer Genetics in Clinical Practice

A Guide to Cancer Genetics in Clinical Practice

BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.

This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.

View Flyer / Purchasing Details [ 38 Kb ]

Publication date: June 2009


BSG Guidance on Coeliac Disease 2010

The Management of Adults with Coeliac Disease


There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.

An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).

The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).

In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.


BSG Response to White Paper: 'Healthy Lives, Healthy People'

Responses to Public Health White Paper: 'Healthy Lives, Healthy People: Our Strategy for Public Health in England'

Submitted 31st March 2011

BSG Response

Joint Response

The organisations that contributed to the joint response are:

  • The British Association for the Study of the Liver
  • The British Society of Gastroenterology
  • The British Liver Trust
  • The Hepatitis C Trust
  • Alcohol Concern

Page 4 of 15